Novo Nordisk A/S Common Stock (NVO)

Total Current Assets

kr 208.70B

Quarterly · Period ending: · DKK

NVO logo

NVO Total Current Assets

Latest reportedkr 208.70B DKK
NVO Quarterly Current Assets · DKK (kr 4.29B → kr 208.70B)
High-resolution chart · PNG

NVO total current assets history

Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Total Current Assets — Quarterly (DKK)
Period endingTotal Current Assets (DKK)
208,696,000,000
177,317,000,000
172,453,000,000
181,883,000,000
162,705,000,000
174,395,000,000
160,897,000,000
195,160,000,000
25,509,470,840
116,421,000,000
139,646,000,000
20,189,544,525
20,154,435,628
16,618,124,275
108,194,000,000
15,742,236,393
14,476,863,924
12,944,273,673
85,595,000,000
14,216,268,449
12,302,908,038
9,701,246,059
10,817,621,435
11,605,214,446
11,087,937,672
9,291,995,059
9,382,003,905
63,400,000,000
58,720,000,000
52,734,000,000
59,067,000,000
54,135,000,000
57,502,000,000
49,915,000,000
60,080,000,000
57,094,000,000
58,974,000,000
55,648,000,000
59,766,000,000
51,576,000,000
52,626,000,000
46,381,000,000
55,140,000,000
51,488,000,000
47,337,000,000
43,461,000,000
46,293,000,000
41,171,000,000
34,215,000,000
34,506,000,000
42,058,000,000
40,907,000,000
36,525,000,000
35,799,000,000
40,163,000,000
40,895,000,000
35,918,000,000
36,353,000,000
39,591,000,000
38,794,000,000
37,875,000,000
35,467,000,000
37,293,000,000
33,923,000,000
33,780,000,000
31,383,000,000
32,666,000,000
31,008,000,000
29,727,000,000
28,663,000,000
29,137,092,400
27,122,782,700
26,232,025,500
24,726,233,650
24,332,412,000
23,253,241,200
22,933,043,650
20,928,675,000
20,839,412,800
20,522,332,890
20,314,848,000
18,868,599,750
19,529,730,040
18,156,473,700
16,721,640,650
16,328,107,710
17,873,797,170
16,522,900,790
15,550,586,480
15,183,520,870
16,301,313,900
13,751,951,670
13,825,886,550
12,529,114,400
15,931,936,550
13,062,860,020
12,842,270,712
9,753,085,013
9,634,212,800
13,204,066,260
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.